Addiction Treatment Access Improvement Act of 2017

Bill: 115-hr-3692
Sponsor: full_name: Rep. Tonko, Paul [D-NY-20]
Introduced: 2017-09-07
Policy area: Crime and Law Enforcement
Subjects: Drug therapy

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health personnel

Prescription drugs
Latest action: action_date: 2018-04-25
text: Subcommittee Consideration and Mark-up Session Held.

Summaries:
action_date: 2017-09-07
action_desc: Introduced in House
text: <p><b>Addiction Treatment Access Improvement Act of 2017</b></p> <p>This bill amends the Controlled Substances Act to revise the qualifications required for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.</p> <p>It increases the maximum patient limit for a qualifying practitioner who meets certain requirements. The maximum patient limit is the maximum number of patients a qualifying practitioner can treat at one time.</p> <p>The bill expands qualifying practitioners to include additional nonphysician practitioners: clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives.</p> <p>It makes permanent the authorization for certain nonphysician practitioners to become qualifying practitioners.</p>

tv_txt: I 115th CONGRESS 1st Session H. R. 3692 IN THE HOUSE OF REPRESENTATIVES September 7, 2017 Mr. Tonko (for himself and Mr. Ben Ray Luján of New Mexico ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to provide for additional flexibility with respect to medication-assisted treatment for opioid use disorders, and for other purposes.

1. Short title This Act may be cited as the Addiction Treatment Access Improvement Act of 2017 . 2. Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders (a) Conforming applicable number Subclause (II) of section 303(g)(2)(B)(iii) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(B)(iii) ) is amended to read as follows: (II) The applicable number is— (aa) 100 if, not sooner than 1 year after the date on which the practitioner submitted the initial notification, the practitioner submits a second notification to the Secretary of the need and intent of the practitioner to treat up to 100 patients; or (bb) 275 if the practitioner meets the requirements specified in section 8.610 of title 42, Code of Federal Regulations (or successor regulations). . (b) Eliminating any time limitation for nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, certified nurse midwives, and physician assistants To become qualifying practitioners Section 303(g)(2)(G)(iii)(II) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(iii)(II) ) is amended by striking during the period beginning on the date of enactment of the Comprehensive Addiction and Recovery Act of 2016 and ending on October 1, 2021 and inserting beginning on the date of enactment of the Comprehensive Addiction and Recovery Act of 2016 . (c) Definition of qualifying other practitioner Clause (iv) of section 303(g)(2)(G) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G) ) is amended by striking nurse practitioner or physician assistant each place it appears and inserting nurse practitioner, clinical nurse specialist, certified registered nurse anesthetist, certified nurse midwife, or physician assistant .